10/15/2024 5:00 PM | CRISPR Therapeutics (Issuer) Kulkarni Samarth (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/15/2024 5:00 PM | CRISPR Therapeutics (Issuer) KASINGER JAMES R. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/12/2024 5:45 PM | CRISPR Therapeutics (Issuer) Kulkarni Samarth (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/05/2024 4:22 PM | CRISPR Therapeutics (Filer)
| Form S-3ASR | |
06/24/2024 4:35 PM | Bruno Julianne (Reporting) CRISPR Therapeutics (Issuer) CRISPR Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/03/2024 7:06 AM | CRISPR Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/31/2024 3:50 PM | Behbahani Ali (Reporting) CRISPR Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
05/31/2024 3:50 PM | CRISPR Therapeutics (Issuer) George Simeon (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/23/2024 7:14 AM | CRISPR Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/08/2024 3:15 PM | CRISPR Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/17/2024 4:45 PM | CRISPR Therapeutics (Issuer) Kulkarni Samarth (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/15/2024 3:24 PM | CRISPR Therapeutics (Subject) Kulkarni Samarth (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
04/10/2024 10:58 AM | Capital International Investors (Filed by) CRISPR Therapeutics (Subject)
| Form SC 13G/A | |
04/09/2024 3:42 PM | CRISPR Therapeutics (Filer)
| Form DEF 14A | |
04/09/2024 3:43 PM | CRISPR Therapeutics (Filer)
| Form DEFA14A | |
04/09/2024 3:47 PM | CRISPR Therapeutics (Filer)
| Form ARS | |
03/27/2024 3:30 PM | CRISPR Therapeutics (Filer)
| Form PRE 14A | |
03/27/2024 3:30 PM | CRISPR Therapeutics (Filer)
| Form PRE 14A | |
03/22/2024 4:45 PM | CRISPR Therapeutics (Issuer) Kulkarni Samarth (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/22/2024 4:45 PM | CRISPR Therapeutics (Issuer) Prasad Raju (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/22/2024 4:45 PM | CRISPR Therapeutics (Issuer) KASINGER JAMES R. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/22/2024 3:02 PM | CRISPR Therapeutics (Subject) Morrow Phuong Khanh (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/18/2024 4:45 PM | CRISPR Therapeutics (Issuer) Kulkarni Samarth (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/18/2024 4:45 PM | CRISPR Therapeutics (Issuer) Prasad Raju (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/15/2024 3:43 PM | CRISPR Therapeutics (Subject) Kulkarni Samarth (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/12/2024 4:45 PM | CRISPR Therapeutics (Issuer) Kulkarni Samarth (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/12/2024 4:45 PM | CRISPR Therapeutics (Issuer) KASINGER JAMES R. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/27/2024 5:39 PM | CRISPR Therapeutics (Issuer) George Simeon (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/21/2024 4:45 PM | CRISPR Therapeutics (Issuer) Kulkarni Samarth (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/21/2024 4:45 PM | CRISPR Therapeutics (Issuer) KASINGER JAMES R. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/21/2024 6:45 AM | CRISPR Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/21/2024 6:50 AM | CRISPR Therapeutics (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/16/2024 4:45 PM | CRISPR Therapeutics (Issuer) Kulkarni Samarth (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 3:30 PM | CRISPR Therapeutics (Subject) Kulkarni Samarth (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/13/2024 4:22 PM | CRISPR Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/13/2024 7:44 AM | CRISPR Therapeutics (Filer)
| Form 424B5 | |
02/13/2024 5:30 AM | CRISPR Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/13/2024 5:30 AM | CRISPR Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/12/2024 5:22 PM | CRISPR Therapeutics (Subject) Nikko Asset Management Americas, Inc. (Filed by)
| Form SC 13G/A | |
02/05/2024 5:08 AM | CRISPR Therapeutics (Subject) Sumitomo Mitsui Trust Holdings, Inc. (Filed by)
| Form SC 13G/A | |
01/31/2024 4:45 PM | CRISPR Therapeutics (Issuer) Kulkarni Samarth (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
This man beat out 16,000 stock pickers to earn the #1 spot (Ad) There are very few people in this world who are considered “the best” in their field.
There are guys like Michael Jordan who is considered the best basketball player of all time…
Or Warren Buffet who is considered the best Investor of all time…
But we’ve just met a man who might be the best stock picker of all time…
Right now, as we speak, he is currently ranked the #1 stock picker in North America. If you’d like to sit down with us, follow this link here. |
01/29/2024 3:00 PM | ARK Investment Management LLC (Filed by) CRISPR Therapeutics (Subject)
| Form SC 13G/A | |
01/18/2024 4:45 PM | CRISPR Therapeutics (Issuer) Kulkarni Samarth (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/10/2024 10:36 AM | ARK Investment Management LLC (Filed by) CRISPR Therapeutics (Subject)
| Form SC 13G/A | |
12/15/2023 7:58 AM | CRISPR Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/13/2023 8:22 AM | CRISPR Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/08/2023 12:16 PM | CRISPR Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/16/2023 6:21 AM | CRISPR Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/06/2023 3:42 PM | CRISPR Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/06/2023 3:33 PM | CRISPR Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/17/2023 4:52 PM | CRISPR Therapeutics (Issuer) Morrow Phuong Khanh (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/17/2023 4:52 PM | CRISPR Therapeutics (Issuer) Prasad Raju (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/17/2023 4:48 PM | CRISPR Therapeutics (Issuer) KASINGER JAMES R. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/17/2023 4:51 PM | CRISPR Therapeutics (Issuer) Kulkarni Samarth (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |